Goodpath operates an AI-driven virtual platform that delivers integrated care pathways across weight management, MSK pain, sleep, digestive health, mental health, diabetes, and cancer survivorship. The platform combines AI insights with a multidisciplinary medical team spanning 20+ specialties, unlimited 1:1 coaching, and home-delivered tools to unify care that is typically fragmented. Goodpath's learning care model is fed by more than 4.5 million real-world data points from member assessments, treatments, outcomes, and interactions, which the company says improves personalization and outcome prediction over time. The company reports 15–20% enrollment across eligible populations (and notes enrollment exceeding 20% in some cohorts), roughly five times the industry average, and cites validated studies showing reductions in total medical spend. Goodpath is adopted across Fortune 500 employers, benefits partners, and insurers and emphasizes cost savings for self-insured employers through reduced claims. Planned product investments include outcome prediction models, AI-led personalization tools, expanded prescribing, additional care pathways, and complex care navigation. Goodpath operates a telehealth platform that delivers personalized, integrative care programs for sleep, back pain and Irritable Bowel Syndrome. Its programs are tailored to each patient and can include nutrition and supplements (nutrition coaching and targeted supplements); movement and lifestyle (online yoga and strengthening exercises); mindfulness and meditation (guided meditations and journaling); and one-on-one coaching and guidance. The company was co-founded by CEO Bill Gianoukos, COO & CPO Carl Nehme, and Chief Medical Advisor Dr. Akl Fahed. Goodpath raised $4 million in seed funding to support its growth. The startup intends to use the funds to expand operations and broaden its business reach.

Total raised

$22M

Funding rounds

2

Latest round

Series A

Latest activity

Sep 2025